| Insulin aspart Sanofi (Trurapi): Biosimilar Insulin Aspart |
Evaluation report |
March 2022 |
| Omalizumab and dupilumab for chronic rhinosinusitis with nasal polyps |
Evaluation report |
September 2021 |
| Solriamfetol for obstructive sleep apnoea |
Evaluation report |
June 2021 |
| Solriamfetol for narcolepsy |
Evaluation report |
May 2021 |
| Doxylamine and pyridoxine (Xonvea) for the treatment of nausea and vomiting of pregnancy |
Evaluation report |
February 2019 |
| ActiPatch for the management of localised musculoskeletal pain |
Evaluation report |
January 2019 |
| Naloxone nasal spray for opioid overdose |
Evaluation report |
September 2018 |
